West Pharmaceutical Services, Inc. (BVMF:W2ST34)

Market Cap	108.47B
Revenue (ttm)	16.08B
Net Income (ttm)	2.62B
Shares Out	n/a
EPS (ttm)	35.98
PE Ratio	41.39
Forward PE	37.90
Dividend	0.09 (0.22%)
Ex-Dividend Date	Nov 11, 2025

Volume	28
Average Volume	118
Open	40.76
Previous Close	43.20
Day's Range	40.76 - 40.76
52-Week Range	32.64 - 60.00
Beta	1.17
RSI	49.97
Earnings Date	Feb 20, 2026

About BVMF:W2ST34

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: W2ST34

Financial Performance

In 2024, BVMF:W2ST34's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Financial numbers in USD